-
EP2627648
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2627648
| EP2627648 - 17aHYDROXYLASE/C17,20-LYASE INHIBITORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.01.2016 Database last updated on 02.11.2024 | Most recent event Tooltip | 17.03.2017 | Change - priority | published on 19.04.2017 [2017/16] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2013/34] | Inventor(s) | 01 /
BOCK, Mark G. Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139 / US | 02 /
GAUL, Christoph Novartis Pharma AG Werk Klybeck Postfach CH-4002 Basel / CH | 03 /
GUMMADI, Venkateshwar Rao Aurigene Discovery Technologies Limited 39-40 KIADB Industrial Area Electronic City Phase II Hosur Road Bangalore, Karnataka 560 100 / IN | 04 /
MOEBITZ, Henrik Novartis Pharma AG Werk Klybeck Postfach CH-4002 Basel / CH | 05 /
SENGUPTA, Saumitra Aurigene Discovery Technologies Limited 39-40 KIADB Industrial Area Electronic City Phase II Hosur Road Bangalore, Karnataka 560 100 / IN | [2013/34] | Representative(s) | Strang, Andrea Josephine, et al Novartis Pharma AG Patent Department Postfach 4002 Basel / CH | [N/P] |
| Former [2013/34] | Strang, Andrea Josephine, et al Novartis Pharma AG Patent Department Lichtstrasse 35 4056 Basel / CH | Application number, filing date | 11761540.1 | 14.09.2011 | WO2011EP65965 | Priority number, date | IN2010CHE2719 | 16.09.2010 Original published format: IN 2719CH2010 | [2017/16] |
| Former [2013/34] | IN2010CHE2719 | 16.09.2010 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012035078 | Date: | 22.03.2012 | Language: | EN | [2012/12] | Type: | A1 Application with search report | No.: | EP2627648 | Date: | 21.08.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 22.03.2012 takes the place of the publication of the European patent application. | [2013/34] | Search report(s) | International search report - published on: | EP | 22.03.2012 | Classification | IPC: | C07D401/04, C07D471/04, C07D471/14, C07D495/04, A61K31/435, A61K31/4725, A61P35/00 | [2013/34] | CPC: |
C07D401/04 (EP,US);
A61K31/473 (US);
A61K31/4365 (US);
A61K31/437 (US);
A61K31/4725 (US);
A61K31/506 (US);
A61K45/06 (US);
A61P35/00 (EP);
A61P43/00 (EP);
C07D401/14 (EP,US);
C07D471/04 (EP,US);
C07D471/14 (EP,US);
C07D495/04 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/34] | Title | German: | 17a-HYDROXYLASE-C17, 20-LYASE-INHIBITOREN | [2013/34] | English: | 17aHYDROXYLASE/C17,20-LYASE INHIBITORS | [2013/34] | French: | INHIBITEURS DE LA 17a-HYDROXYLASE/C17,20-LYASE | [2013/34] | Entry into regional phase | 16.04.2013 | National basic fee paid | 16.04.2013 | Designation fee(s) paid | 16.04.2013 | Examination fee paid | Examination procedure | 16.04.2013 | Examination requested [2013/34] | 20.01.2014 | Amendment by applicant (claims and/or description) | 29.08.2014 | Despatch of a communication from the examining division (Time limit: M06) | 02.03.2015 | Reply to a communication from the examining division | 16.04.2015 | Communication of intention to grant the patent | 27.08.2015 | Application deemed to be withdrawn, date of legal effect [2016/07] | 30.09.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2016/07] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 29.08.2014 | Request for further processing for: | The application is deemed to be withdrawn due to failure to file a copy of earlier search results or a statement of non-availability | 11.08.2014 | Request for further processing filed | 11.08.2014 | Full payment received (date of receipt of payment) Request granted | 20.08.2014 | Decision despatched | Fees paid | Renewal fee | 12.09.2013 | Renewal fee patent year 03 | 12.09.2014 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.09.2015 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2010090347 (TAISHO PHARMACEUTICAL CO LTD [JP], et al); | [X]EP2223919 (NIPPON SODA CO [JP]); | [AP]WO2010149755 (NOVARTIS AG [CH], et al); | by applicant | US4100274 | US4636505 | US4659516 | EP0288053 | EP0413270 | US5010099 | US5093330 | WO9215404 | EP0520722 | EP0564409 | WO9320097 | EP0566226 | WO9410202 | WO9427989 | WO9503283 | WO9509157 | WO9509178 | US5461076 | US5491161 | WO9614090 | WO9630347 | WO9633980 | WO9700257 | WO9702266 | EP0769947 | EP0787722 | WO9730034 | WO9738983 | WO9749688 | WO9808849 | WO9810121 | WO9810767 | WO9811223 | EP0837063 | US5747498 | WO9822461 | WO9825929 | WO9835958 | US5843901 | WO9903854 | WO9918075 | WO9917804 | WO9943653 | WO9954309 | WO0009495 | WO0027820 | WO0027819 | WO0031247 | WO0037502 | WO0059509 | US6194181 | WO02092599 | WO03013541 | US2004198773 | WO2006021776 | WO2008024485 | US2008280864 | WO2009000132 |